BioCentury | Sep 13, 2018
Translation in Brief

New Therapeutic Targets and Biomarkers: August 2018

...AD, PSP and other tauopathies University of Texas Health Science Center Distillery Therapeutics Huntington’s disease Protein phosphatase 1 regulatory subunit 15B (PPP1R15B)...
BioCentury | Aug 1, 2018
Distillery Therapeutics

Neurology

...with vehicle. Next steps could include testing the compound in additional models of HD. TARGET/MARKER/PATHWAY: Protein phosphatase 1 regulatory subunit 15B (PPP1R15B)...
...Cambridge, U.K. email: aberto@mrc-lmb.cam.ac.uk Elizabeth S. Eaton Medical Research Council Laboratory of Molecular Biology (MRC LMB) Huntington's disease (HD) Protein phosphatase 1 regulatory subunit 15B (PPP1R15B)...
BioCentury | May 11, 2015
Emerging Company Profile

Preventing accumulation

InFlectis BioScience S.A.S. is developing preclinical small molecules for Orphan diseases to slow production of misfolded proteins whose accumulation leads to disease. The goal is to turn up one of the three components of the...
Items per page:
1 - 3 of 3